Physician profile
Charles Michael Wright
NPI 1104861459
$1,389.46
in general payments reported to CMS, 2019-2025
33 companies · $22.88 in 2025
The $22.88 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $14.48 · 2020: $178 · 2021: $180 · 2022: $298 · 2023: $242 · 2024: $455 · 2025: $22.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $719.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $187.25 | 2024 | Inspire |
| Amgen INC. | $102.26 | 2020-2022 | |
| Novartis Pharmaceuticals Corporation | $102.20 | 2020-2023 | |
| Glaxosmithkline, LLC. | $93.76 | 2021-2023 | Arexvy, Shingrix, Trelegy Ellipta |
| Phadia US INC. | $83.58 | 2024 | Immunocap |
| Boehringer Ingelheim Pharmaceuticals, INC. | $62.34 | 2022-2023 | Jardiance |
| Novo Nordisk INC | $60.86 | 2022-2024 | Ozempic, Rybelsus |
| Hologic Sales and Service, LLC | $60.46 | 2024 | Aptima |
| Lilly USA, LLC | $54.44 | 2020-2023 | Emgality, Reyvow |
| Bayer Healthcare Pharmaceuticals INC. | $50.17 | 2022 | |
| Amarin Pharma, INC. | $46.88 | 2020-2021 | |
| Exact Sciences Corporation | $41.72 | 2023-2024 | Cologuard Collection Kit |
| Dexcom, INC. | $40.30 | 2021 | |
| Esperion Therapeutics, INC. | $31.83 | 2023 | Nexletol |
| Janssen Pharmaceuticals, INC | $26.86 | 2021 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $25.41 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Biohaven Pharmaceuticals, INC. | $25.00 | 2021 | |
| Ibsa Pharma INC. | $24.94 | 2021 | |
| Merck Sharp & Dohme LLC | $24.85 | 2020 | |
| Irhythm Technologies, INC. | $23.84 | 2024 | Zio Xt Patch, Zio Monitor |
| Philips North America LLC | $23.41 | 2024 | (Ck7) Extended Holter |
| Regeneron Healthcare Solutions, INC. | $22.88 | 2025 | Dupixent |
| Astellas Pharma US INC | $22.32 | 2022 | |
| Genentech USA, INC. | $21.15 | 2020 | |
| Astrazeneca Pharmaceuticals Lp | $18.32 | 2024 | Breztri |
| E.R. Squibb & Sons, L.L.C. | $17.46 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.35 | 2024 | Xifaxan, Trulance |
| Therapeuticsmd, INC. | $15.70 | 2021 | |
| Xeris Pharmaceuticals, INC. | $15.64 | 2022 | |
| Bausch Health US, LLC | $15.56 | 2023 | Aplenzin |
| Abbott Laboratories | $15.41 | 2022 | |
| Lantheus Medical Imaging, INC. | $14.48 | 2019 | |
| Travere Therapeutics, INC. | $0.83 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.